Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;228(2):160-4.
doi: 10.1016/j.expneurol.2010.12.022. Epub 2011 Jan 4.

Preclinical jockeying on the translational track of adenosine A2A receptors

Melita T Barkhoudarian  1 , Michael A Schwarzschild
Affiliations
Review

Preclinical jockeying on the translational track of adenosine A2A receptors

Melita T Barkhoudarian et al. Exp Neurol. 2011 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer's disease. J. Alzheimers Dis. 2010;20 Suppl 1:S117–S126. - PubMed
    1. Ascherio A, Zhang SM, Hernán MA, Kawachi I, Colditz GA, Speizer FE, Willett WC. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann. Neurol. 2001;50(1):56–63. - PubMed
    1. Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M, Morris MJ, Mouradian MM, Chase TN. Adenosine A2A receptor antagonist treatment of Parkinson's disease. Neurology. 2003;61(3):293–296. - PubMed
    1. Bata-García JL, Tun-Cobá L, Alvarez-Cervera FJ, Villanueva-Toledo JR, Heredia-López FJ, Góngora-Alfaro JL. Improvement of postural adjustment steps in hemiparkinsonian rats chronically treated with caffeine is mediated by concurrent blockade of A1 and A2A adenosine receptors. Neuroscience. 2010;166(2):590–603. - PubMed
    1. Bibbiani F, Oh JD, Petzer JP, Castagnoli N, Jr, Chen JF, Schwarzschild MA, Chase TN. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Exp. Neurol. 2003;184(1):285–294. - PubMed

Publication types

MeSH terms

Substances